Current Enterprise Value (EV)
| Current share price (P) | $108.03 |
| No. shares of common stock outstanding | 711,714,480 |
| US$ in millions | |
| Common equity (market value)1 | 76,887) |
| Add: Preferred stock, $.01 par value per share; none outstanding (per books) | —) |
| Total equity | 76,887) |
| Add: Short-term borrowings and current portion of long-term debt (per books) | 501) |
| Add: Long-term debt, net of discount, excluding current portion (per books) | 19,769) |
| Total equity and debt | 97,157) |
| Less: Cash and cash equivalents | 4,234) |
| Less: Debt securities available-for-sale | 496) |
| Less: Equity investments with readily determinable fair values | 1,312) |
| Less: Marketable securities available-for-sale | —) |
| Enterprise value (EV) | 91,115) |
Based on: 10-K (reporting date: 2018-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 108.03 × 711,714,480
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Celgene Corp. Annual Report.
3 2018 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 89.71 × 702,164,345